Search & Filter

Cancer Research Technology and Medivir have announced a partnership to develop a new class of drugs that has shown promise for treating a range of different cancers, especially breast and pancreatic cancer.

Only a minority of teenagers who try e-cigarettes go on to become regular users, according to two surveys (link is external) of children in Wales.

A map to help local charities and public services find and support those experiencing and at risk of loneliness is needed to ensure resources are allocated where they are needed most according to a report by the University of Kent.

Long-term antiplatelet therapy with aspirin can significantly cut the risk of heart attack, stroke or cardiovascular death in patients with a history of heart attack according to the findings of a study of more than 21,000 people.

The Scottish Medicines Consortium has announced that that Duaklir Genuair has been accepted for use as a maintenance bronchodilator to relieve symptoms in adult patients with chronic obstructive pulmonary disease in Scotland.

A newly updated version of a free online training resource designed to give all NHS staff training on the use of the National Early Warning Score has been launched.

Cancer Research UK and the Medical Research Council (MRC) have jointly launched a Stratified Medicine Consortium to help personalise by matching patients to the most effective therapies.

Researchers have developed an experimental treatment to overcome resistance to drugs used to treat cancers of the blood.

The European Medicines Agency is revising the way drugmakers conduct studies for drugs to treat blood clots, for the first time separating out the clinical requirements for different types of clots.

Researchers have discovered that a vital self-destruct switch in cells is hijacked - making some pancreatic and non small cell lung cancers more aggressive, according to a report in Cancer Cell.

A test for a wide range of genetic risk factors could improve doctors' ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown.

Front-line clinicians say lack of coordination between teams delivering care, insufficient funding for services and time-poor staff are barriers to meeting the needs of people with a terminal illness, according to a new survey.

A new film to raise awareness and increase knowledge of hepatitis C among GPs and other primary care practitioners has been launched by the Royal College of GPs, the Hepatitis C Trust and HCV Action.

Accurately predicting the probability of a live birth after IVF treatment is important for both those undergoing the treatment and their clinicians. Findings from a comparison study that analysed the accuracy of the two most widely-used prediction models have been published in the journal PLOS ONE.

Boehringer Ingelheim has announced that idarucizumab has been submitted for approval of marketing authorisation to the European Medicines Agency (EMA), US Food and Drug Administration (FDA) and Health Canada.